Mr. Speaker, the debate concerning CCSVI should be based on science, evidence, and improving the quality of life for Canadians with MS, who wonder how the government is going to judge the radically different CCSVI data from the east and west of Canada.
Canadians with MS ask, if the debate had been based on evidence, why the Minister of Health did not meet with CCSVI groups across the country and with Canadians who had been treated to learn about their experience, why she did not include experts in CCSVI in her expert working group, and why the decision to kill Bill S-204 was taken eight months before the Senate hearings.
The petitioners are calling upon the minister to consult experts, to undertake Phase III clinical trials on an urgent basis, and to require follow-up care.